Brief: AVROBIO Receives Rare Pediatric Disease Designation From U.S. FDA For First Gene Therapy In Development For Cystinosis

Tectonic Therapeutic

20/09/2022 12:27

Sept 20 (Reuters) - AVROBIO Inc  AVRO.O :
    * AVROBIO RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM
U.S.
FOOD AND DRUG ADMINISTRATION (FDA) FOR FIRST GENE THERAPY IN
DEVELOPMENT FOR CYSTINOSIS

Source text for Eikon:  ID:nBw4g0rJfa 
Further company coverage:  AVRO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))